Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Not Confirmed
Not Confirmed
03-05 April, 2025
Not Confirmed
Not Confirmed
05-09 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Peptide Therapy SummitPeptide Therapy Summit
Industry Trade Show
Not Confirmed
03-05 April, 2025
Industry Trade Show
Not Confirmed
05-09 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050301/0/en/Alvotech-Appoints-Dr-Balaji-V-Prasad-as-Chief-Strategy-Officer.html
26 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/26/3050210/0/en/Alvotech-Reports-Record-Results-for-2024-and-Provides-Business-Update.html
20 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/20/3045967/0/en/Alvotech-Acquires-Xbrane-s-R-D-Operations-in-Sweden-and-Further-Affirms-its-Global-Leadership-Position-in-Biosimilars-Development-and-Production.html
19 Mar 2025
// PRESS RELEASE
https://investors.alvotech.com/news-releases/news-release-details/alvotech-and-dr-reddys-announce-fda-acceptance-biologic-license
18 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250318655326/en/Alvotech-and-Dr.-Reddys-Announce-FDA-Acceptance-of-Biologic-License-Application-for-AVT03-a-Proposed-Biosimilar-to-Prolia-and-Xgeva
07 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/07/3038968/0/en/Alvotech-Meeting-Investors-and-Participates-in-Fireside-Chat-At-Barclays-27th-Global-Healthcare-Conference-in-Miami-Florida.html
ABOUT THIS PAGE